Portfolio: Investments
Syndax Pharmaceuticals, Inc.
Novel combination regimens for cancer
Theraclone Sciences
Novel tumor-specific therapeutic antibodies
TriVascular, Inc.
Novel endovascular repair devices to treat abdominal aortic aneurysms
Valeritas
Drug delivery services
Verastem
Novel drugs that selectively target cancer stem cells
VLST Corporation
Inflammatory and autoimmune disease therapeutics




